{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:51:37Z","timestamp":1793040697351,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00415-013-7079-8","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:48:24Z","timestamp":1377737304000},"page":"2844-2848","source":"Crossref","is-referenced-by-count":39,"title":["Levodopa, vitamins, ageing and the neuropathy of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"260","author":[{"given":"Yusuf A.","family":"Rajabally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Martey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"7079_CR1","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","volume":"23","author":"C Toth","year":"2008","unstructured":"Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D (2008) Neuropathy as a potential complication of levodopa use in Parkinson\u2019s disease. Mov Disord 23:1850\u20131859","journal-title":"Mov Disord"},{"key":"7079_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","volume":"67","author":"C Toth","year":"2010","unstructured":"Toth C, Breithaupt K, Ge S et al (2010) Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson\u2019s disease. Ann Neurol 67:28\u201336","journal-title":"Ann Neurol"},{"key":"7079_CR3","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Martey J (2011) Neuropathy in Parkinson disease. Prevalence and determinants. Neurology 77:1947\u20131950","journal-title":"Neurology"},{"key":"7079_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","volume":"13","author":"JR Singleton","year":"2008","unstructured":"Singleton JR, Bixby B, Russell JW et al (2008) The Utah early neuropathy scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 13:218\u2013227","journal-title":"J Peripher Nerv Syst"},{"key":"7079_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","volume":"72","author":"JD England","year":"2009","unstructured":"England JD, Gronseth GS, Franklin G, American Academy of Neurology et al (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American academy of neurology, American association of neuromuscular and electrodiagnostic medicine, and American academy of physical medicine and rehabilitation. Neurology 72:185\u2013192","journal-title":"Neurology"},{"key":"7079_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2003.10719270","volume":"22","author":"G Rampersaud","year":"2003","unstructured":"Rampersaud G, Kauwell GP, Bailey LB (2003) Folate: a key to optimizing health and reducing disease risk in the elderly. J Am Coll Nutr 22:1\u20138","journal-title":"J Am Coll Nutr"},{"key":"7079_CR7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1017\/S0007114508958001","volume":"100","author":"P Clarke","year":"2008","unstructured":"Clarke P, Sherliker P, Hin H et al (2008) Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr 100:1054\u20131059","journal-title":"Br J Nutr"},{"key":"7079_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.neuropsych.15.1.64","volume":"15","author":"J R\u00f6sche","year":"2003","unstructured":"R\u00f6sche J, Uhlmann C, Fr\u00f6scher W (2003) Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. J Neuropsychiatry Clin Neurosci 15:64\u201366","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"7079_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ajcn\/85.1.193","volume":"85","author":"MS Morris","year":"2007","unstructured":"Morris MS, Jacques PF, Rosenberg IH, Selhub J (2007) Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85:193\u2013200","journal-title":"Am J Clin Nutr"},{"issue":"S4","key":"7079_CR10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/mds.5558","volume":"17","author":"Taskforce of the Movement Disorder Society","year":"2002","unstructured":"Taskforce of the Movement Disorder Society (2002) Management of Parkinson\u2019s disease: an evidence-based review. Levodopa. Mov Disord 17(S4):S23\u2013S37","journal-title":"Mov Disord"},{"key":"7079_CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1079\/PHN200167","volume":"5","author":"A Wahlin","year":"2002","unstructured":"Wahlin A, B\u00e4ckman L, Hultdin J, Adolfsson R, Nilsson LG (2002) Reference values of serum vitamin B12 and folic acid in a population-based sample of adults between 35 and 80\u00a0years of age. Public Health Nutr 5:505\u2013511","journal-title":"Public Health Nutr"},{"key":"7079_CR12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/bmj.1.6019.1176","volume":"1","author":"M Manzoor","year":"1976","unstructured":"Manzoor M, Runcie J (1976) Folate-responsive neuropathy: report of 10 cases. Br Med J 1:1176\u20131178","journal-title":"Br Med J"},{"key":"7079_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archneur.1978.00500330029005","volume":"35","author":"MI Botez","year":"1978","unstructured":"Botez MI, Peyronnard JM, Bachevalier J, Charron L (1978) Polyneuropathy and\u00a0folate deficiency. Arch Neurol 35:581\u2013584","journal-title":"Arch Neurol"},{"key":"7079_CR14","first-page":"131","volume":"23","author":"TE Parry","year":"1994","unstructured":"Parry TE (1994) Folate responsive neuropathy. Presse Med 23:131\u2013137","journal-title":"Presse Med"},{"key":"7079_CR15","first-page":"57","volume":"18S2","author":"H Koike","year":"2013","unstructured":"Koike H, Takahashi M, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, Sobue G (2013) The significance of folate deficiency in peripheral neuropathy. Abstract meeting of the peripheral nerve society. J Peripher Nerv Syst 18S2:57","journal-title":"J Peripher Nerv Syst"},{"key":"7079_CR16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneur.61.5.657","volume":"61","author":"T M\u00fcller","year":"2004","unstructured":"M\u00fcller T, Renger K, Kuhn W (2004) Levodopa-associated increase in homocysteine levels and sural axonal degeneration. Arch Neurol 61:657\u2013660","journal-title":"Arch Neurol"},{"key":"7079_CR17","doi-asserted-by":"crossref","unstructured":"Ceravolo R, Cossu G, Bandettini di Poggio M et al (2013) Neuropathy and Levodopa in Parkinson\u2019s disease: evidence from a multicentre study. Mov Disord [E-Pub ahead of print]","DOI":"10.1002\/mds.25585"},{"key":"7079_CR18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.22878","volume":"25","author":"JL Montastruc","year":"2010","unstructured":"Montastruc JL, Danton AC, Durrieu G, French Association of Regional Pharmocovigilance Centres et al (2010) Neuropathy as a potential complication of levodopa use in Parkinson\u2019s disease: a pharmacological and pharmacovigilance point of view. Mov Disord 25:660\u2013661","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7079-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7079-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7079-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T10:21:31Z","timestamp":1563790891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7079-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["7079"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7079-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}